Pharmaco‐genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndrome

J. Cubells,Elizabeth deOreo,Philip D. Harvey,S. Garlow,K. Garber,M. Adam,C. Martin
DOI: https://doi.org/10.1002/ajmg.a.33917
2011-04-01
Abstract:15q13.3 deletion syndrome (15q13.3DS) is a common recurrent genomic disorder associated with epilepsy, intellectual impairment, aggressive behavior, schizophrenia, and autism. A 39‐year‐old male presented with 15q13.3DS, epilepsy, intellectual impairment, psychosis, and recurrent episodes of aggressive rage. We hypothesized that the patient's aggressive behavior reflected deficits in α7 nicotinic cholinergic receptor (NChR)‐mediated neurotransmission, arising from haploinsufficiency of the structural gene CHRNA7 due to the deletion. Treatment with the NChR allosteric modulator and acetylcholinesterase (AChE) inhibitor, galantamine, led to a dramatic decline in the frequency and intensity of rage outbursts, suggesting that enhancement of α7 NChR function can ameliorate 15q13.3DS‐associated rage outbursts. © 2011 Wiley‐Liss, Inc.
What problem does this paper attempt to address?